RJA
CNS icon

Raymond James & Associates’s Cohen & Steers CNS Stock Holding History

Raymond James & Associates’s Portfolio CNS Stock Details CNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$22.6M Sell
235,464
-23,788
-9% -$2.02M 0.01% 752
2024
Q2 		$18.8M Buy
259,252
+8,086
+3% +$575K 0.01% 812
2024
Q1 		$19.3M Buy
251,166
+50,222
+25% +$3.58M 0.01% 795
2023
Q4 		$15.2M Buy
200,944
+56,153
+39% +$3.38M 0.01% 860
2023
Q3 		$9.08M Buy
144,791
+7,598
+6% +$481K 0.01% 1093
2023
Q2 		$7.96M Buy
137,193
+12,802
+10% +$747K 0.01% 1198
2023
Q1 		$7.96M Buy
124,391
+11,325
+10% +$790K 0.01% 1167
2022
Q4 		$7.3M Buy
113,066
+30,783
+37% +$1.93M 0.01% 1184
2022
Q3 		$5.15M Buy
82,283
+4,903
+6% +$351K 0.01% 1363
2022
Q2 		$4.92M Buy
77,380
+2,708
+4% +$205K ﹤0.01% 1415
2022
Q1 		$6.41M Buy
74,672
+5,509
+8% +$456K 0.01% 1326
2021
Q4 		$6.4M Buy
69,163
+3,540
+5% +$328K 0.01% 1384
2021
Q3 		$5.5M Buy
65,623
+2,393
+4% +$203K ﹤0.01% 1441
2021
Q2 		$5.19M Sell
63,230
-3,227
-5% -$233K ﹤0.01% 1471
2021
Q1 		$4.34M Buy
66,457
+6,254
+10% +$427K ﹤0.01% 1505
2020
Q4 		$4.47M Buy
60,203
+11,087
+23% +$731K ﹤0.01% 1403
2020
Q3 		$2.74M Sell
49,116
-2,573
-5% -$159K ﹤0.01% 1562
2020
Q2 		$3.52M Buy
51,689
+17,786
+52% +$1.07M ﹤0.01% 1405
2020
Q1 		$1.54M Sell
33,903
-8,321
-20% -$526K ﹤0.01% 1722
2019
Q4 		$2.65M Sell
42,224
-18,054
-30% -$1.14M ﹤0.01% 1651
2019
Q3 		$3.31M Buy
60,278
+9,169
+18% +$485K ﹤0.01% 1485
2019
Q2 		$2.63M Sell
51,109
-365
-0.7% -$17.9K ﹤0.01% 1634
2019
Q1 		$2.18M Buy
51,474
+3,597
+8% +$140K ﹤0.01% 1707
2018
Q4 		$1.64M Sell
47,877
-7,161
-13% -$265K ﹤0.01% 1781
2018
Q3 		$2.23M Buy
55,038
+816
+2% +$34.2K ﹤0.01% 1745
2018
Q2 		$2.26M Buy
+54,222
New +$2.18M ﹤0.01% 1685

Other funds holding CNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

Raymond James & Associates's CNS Position: Q3 2024 in Review

Raymond James & Associates reduced its Cohen & Steers (CNS) stake by 9.2% in Q3 2024, selling an estimated $2.02M and leaving 235,464 shares worth $22.6M. The position accounts for 0.01% of the portfolio, ranked #752.

Raymond James & Associates first reported a position in CNS in Q2 2018 and has held it in 26 quarters since. 258 funds tracked by Wall St. Rank hold CNS as of Q3 2024.

  • Raymond James & Associates held 235,464 shares of Cohen & Steers worth $22.6M as of Q3 2024.
  • Raymond James & Associates sold 23,788 Cohen & Steers shares in Q3 2024, an estimated $2.02M.
  • Cohen & Steers made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #752 holding.
  • Raymond James & Associates first reported a position in Cohen & Steers in Q2 2018 and has held it in 26 quarters since.
  • 258 funds tracked by Wall St. Rank held Cohen & Steers as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.